Group testing performance evaluation for SARS-CoV-2 massive scale screening and testing.
Background: The capacity of the current molecular testing convention does not allow high-throughput and community level scans of COVID-19 infections. The diameter in the current paradigm of shallow tracing is unlikely to reach the silent clusters that might be as important as the symptomatic cases i...
| Published in: | BMC Medical Research Methodology Vol. 20; no. 1; pp. 1 - 12 |
|---|---|
| Main Author: | |
| Format: | Journal Article |
| Published: |
BioMed Central
7/2/2020
|
| Online Access: | View this record in EBSCOhost |